openPR Logo
Press release

In Vitro Diagnostics (IVD) Market in Europe Along With Covid-19 Impact Analysis and Business Opportunities Outlook 2027

08-06-2020 03:07 PM CET | Health & Medicine

Press release from: Allied Market Research

Europe IVD Market

Europe IVD Market

According to a new report titled "European In Vitro Diagnostic Market by Product and Service, Technology, Application and End User: Opportunity Analysis and Industry Forecast, 2019-2026," published by Allied Market Research, the European in vitro diagnostic market is rated as follows: Has been. It is expected to reach $13,825 million in 2019 and $18,647 million by 2027, with an average annual growth rate of 4.8% from 2019 to 2027.

In vitro diagnostics is defined as a medical device used to perform diagnostic tests in a laboratory. These tests are performed on samples taken from the patient's body, such as blood, urine, and tissue. In addition, medical devices used for in vitro diagnostics must also be tested using a variety of techniques. For example, blood drawn from a patient is analyzed for hepatitis infection using an enzyme-linked immunosorbent assay technique to analyze the blood.

In addition, testing procedures require the use of a variety of chemicals and reagents and software to ensure smooth operation. In addition, in vitro diagnosis is used to diagnose a variety of medical conditions, including infectious diseases, diabetes, tumors/cancers, heart disease, autoimmune diseases, kidneys, HIV/AIDS, and more. Additionally, these tests are performed in a variety of medical facilities such as hospitals, standalone laboratories, academic and medical schools.

Click here to access sample report: https://www.alliedmarketresearch.com/request-sample/4352

Factors such as rising healthcare awareness, a surge in chronic and communicable disease incidences, and cost-effective diagnostic solutions are driving the growth of the European in vitro diagnostics market. Similarly, increased use of automated devices, a surge in government spending on healthcare in Europe, and accurate and fast test results complement market growth. However, strict regulations and policies and unclear reimbursement rules hinder market growth. In addition, the outsourcing possibilities provide favorable opportunities for major players in the European In Vitro Diagnostics market during the forecast period.

know more: https://www.alliedmarketresearch.com/europe-ivd-market

The report segments the market by products and services, technology, applications, end users, and regions. It is categorized on the basis of products and services into chemicals and reagents, instruments, services and software. Based on technology, it is classified into immunodiagnosis, hematology, molecular diagnosis, tissue diagnosis, and clinical chemistry. Additionally, the immunodiagnostic segment is further divided into types such as enzyme-linked immunosorbent assay (ELISA), rapid test, enzyme-linked immune point (ELISPOT), radioimmunoassay (RIA), and western blot. Additionally, the ELSIA segment is further divided into chemiluminescent immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). Similarly, molecular diagnostic segments are divided into polymerization chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarrays, etc.

By application, the market has been segmented into infectious diseases, cancer, heart diseases, immune system diseases, kidney diseases, gastrointestinal diseases, etc. On the basis of end users, they are classified as standalone laboratories, hospitals, academic and medical schools, point-of-care, and more. By country, the market is analyzed across Germany, France, UK, Italy, Spain and other Europe.

The clinical chemistry division is also further divided into basic metabolic panel, liver panel, lipid profile, thyroid function panel, electrolyte panel, special chemicals, etc.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4352

Key findings of the study
• The reagents segment accounted for more than half of the European in vitro diagnostics market share in 2019.
• Commodity sector is expected to grow to the highest CAGR from 2020 to 2027.
• The epidemic sector accounted for about a third of the European in vitro diagnostics market in 2019.
• Germany accounted for about a fifth of the European in vitro diagnostics market in 2019.
• The UK is expected to provide profitable growth opportunities from 2019 to 2027.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Diagnostics (IVD) Market in Europe Along With Covid-19 Impact Analysis and Business Opportunities Outlook 2027 here

News-ID: 2105615 • Views: 322

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Europe

Synthetic Biology Market – Europe
Synthetic Biology Market Europe is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Synthetic biology has expanded into various interdisciplinary fields that may be defined as the combination of artificial design and engineering to produce biological systems, chemicals or living organisms. Synthetic biology is also used for improving applications
Europe Wooden Doors Market
Europe Wooden Doors Market https://www.qandqmarketresearch.com/reports/wooden-doors-market-78 This report studies the Wooden Doorsmarket status and outlook of Europe and major countries, from angles of players, countries, product types and end industries; this report analyzes the top players in Europe and major countries, and splits the Wooden Doors market by product type and applications/end industries. The global Wooden Doors market is valued at XX million USD in 2018 and is expected to reach XX million
Europe Radiotherapy Market
The Europe Radiotherapy Market research report consists of a primary and secondary research along with an in-depth analysis of the quantitative and qualitative aspects by the expert industry analysts and professionals, leading management bodies, to gain a profound insight of the industry as well as the industry performance. The Europe Radiotherapy Market report presents a lucid picture of the current industry landscape, including the historical and projected market size, based
Europe Business Assembly
The Europe Business Assembly (EBA) is an international corporation for the evolution and implementation of economic and social development. The company was established in April 2000 and its history shows a plethora of promising initiatives, creative growth and professional victories. EBA’s activity demonstrates the capabilities and power of professional partnership. The year 2000 saw the beginning and the foundation of EBA with the signing of the memorandum of cooperation and
Smartsourcing in Eastern Europe
In 2008 the outsourcing business of Eastern Europe was estimated at nearly $2 billion, representing just a tiny fraction of the global IT outsourcing market, estimated at about $386 billion. According to the Gartner Dataquest predictions, in the next four years Eastern Europe is expected to outstrip the rest of the offshore market concentrated mainly in the “classical” locations like India. By 2010 Eastern Europe’s IT outsourcing market share is
Home Control conquers Europe
European Home Control Summit attracts participation from leading International companies and organizations 29. February 2008 - Copenhagen/Frankfurt - The first European Wireless Home Control Summit on 9 April 2008, taking place parallel to Light + Building, features leading companies such as Merten, Horstmann, Danfoss, and market researcher Parks Associates as well as publicly funded organizations like the Danish Energy Saving Trust (DEST) presenting the newest trends, products and market strategies pertaining